Loss of histone methyltransferase SETD1B in oogenesis results in the redistribution of genomic histone 3 lysine 4 trimethylation.
Stewart, A Francis
Nucleic Acids Res
Oxford University Press (OUP)
MetadataShow full item record
Hanna, C., Huang, J., Belton, C., Reinhardt, S., Dahl, A., Andrews, S., Stewart, A. F., et al. (2022). Loss of histone methyltransferase SETD1B in oogenesis results in the redistribution of genomic histone 3 lysine 4 trimethylation.. Nucleic Acids Res, 50 (4), 1993-2004. https://doi.org/10.1093/nar/gkac051
Funder: FP7 People: Marie-Curie Actions; Grant(s): 290123
Histone 3 lysine 4 trimethylation (H3K4me3) is an epigenetic mark found at gene promoters and CpG islands. H3K4me3 is essential for mammalian development, yet mechanisms underlying its genomic targeting are poorly understood. H3K4me3 methyltransferases SETD1B and MLL2 (KMT2B) are essential for oogenesis. We investigated changes in H3K4me3 in Setd1b conditional knockout (cKO) oocytes using ultra-low input ChIP-seq, with comparisons to DNA methylation and gene expression analyses. H3K4me3 was redistributed in Setd1b cKO oocytes showing losses at active gene promoters associated with downregulated gene expression. Remarkably, many regions also gained H3K4me3, in particular those that were DNA hypomethylated, transcriptionally inactive and CpG-rich, which are hallmarks of MLL2 targets. Consequently, loss of SETD1B disrupts the balance between MLL2 and de novo DNA methyltransferases in determining the epigenetic landscape during oogenesis. Our work reveals two distinct, complementary mechanisms of genomic targeting of H3K4me3 in oogenesis, with SETD1B linked to gene expression and MLL2 to CpG content.
European Commission (290123)
External DOI: https://doi.org/10.1093/nar/gkac051
This record's URL: https://www.repository.cam.ac.uk/handle/1810/334951
Attribution 4.0 International
Licence URL: https://creativecommons.org/licenses/by/4.0/